BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 9771840)

  • 21. Loss of myeloid related protein-8/14 exacerbates cardiac allograft rejection.
    Shimizu K; Libby P; Rocha VZ; Folco EJ; Shubiki R; Grabie N; Jang S; Lichtman AH; Shimizu A; Hogg N; Simon DI; Mitchell RN; Croce K
    Circulation; 2011 Dec; 124(25):2920-32. PubMed ID: 22144572
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival of MHC-deficient mouse heterotopic cardiac allografts.
    Campos L; Naji A; Deli BC; Kern JH; Kim JI; Barker CF; Markmann JF
    Transplantation; 1995 Jan; 59(2):187-91. PubMed ID: 7839439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pluripotent allospecific CD8+ effector T cells traffic to lung in murine obliterative airway disease.
    West EE; Lavoie TL; Orens JB; Chen ES; Ye SQ; Finkelman FD; Garcia JG; McDyer JF
    Am J Respir Cell Mol Biol; 2006 Jan; 34(1):108-18. PubMed ID: 16195540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclosporine reduces development of obliterative bronchiolitis in a murine heterotopic airway model.
    King MB; Jessurun J; Savik SK; Murray JJ; Hertz MI
    Transplantation; 1997 Feb; 63(4):528-32. PubMed ID: 9047145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interferon-gamma is necessary for initiating the acute rejection of major histocompatibility complex class II-disparate skin allografts.
    Ring GH; Saleem S; Dai Z; Hassan AT; Konieczny BT; Baddoura FK; Lakkis FG
    Transplantation; 1999 May; 67(10):1362-5. PubMed ID: 10360591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Donor CD8 cells prevent allogeneic marrow graft rejection in mice: potential implications for marrow transplantation in humans.
    Martin PJ
    J Exp Med; 1993 Aug; 178(2):703-12. PubMed ID: 8101864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reproduction of the obliterative bronchiolitis lesion after heterotopic transplantation of mouse airways.
    Hertz MI; Jessurun J; King MB; Savik SK; Murray JJ
    Am J Pathol; 1993 Jun; 142(6):1945-51. PubMed ID: 8506960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Orthotopic and heterotopic tracheal transplantation model in studying obliterative bronchiolitis.
    Fan K; Qiao XW; Nie J; Yuan L; Guo HZ; Zheng ZK; Li JS; Wang JJ; Jiang K
    Transpl Immunol; 2013 Jun; 28(4):170-5. PubMed ID: 23619376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ductal lesions of exocrine glands and insulitis induced by L3T4+ T cells following graft-versus-host reaction due to major histocompatibility complex class II disparity.
    Saitoh T; Fujiwara M; Asakura H
    Clin Immunol Immunopathol; 1990 Dec; 57(3):339-50. PubMed ID: 1978809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of CD28 in acute graft-versus-host disease.
    Yu XZ; Martin PJ; Anasetti C
    Blood; 1998 Oct; 92(8):2963-70. PubMed ID: 9763584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SOCS3 overexpression in T cells ameliorates chronic airway obstruction in a murine heterotopic tracheal transplantation model.
    Mesaki K; Yamane M; Sugimoto S; Fujisawa M; Yoshimura T; Kurosaki T; Otani S; Miyoshi S; Oto T; Matsukawa A; Toyooka S
    Surg Today; 2019 May; 49(5):443-450. PubMed ID: 30617600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tolerance induction of allo-class II H-2 antigen-reactive L3T4+ helper T cells and prolonged survival of the corresponding class II H-2-disparate skin graft.
    Hori S; Sato S; Kitagawa S; Azuma T; Kokudo S; Hamaoka T; Fujiwara H
    J Immunol; 1989 Sep; 143(5):1447-52. PubMed ID: 2527264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protection from T helper cell-mediated graft-versus-host disease by the presence of an MHC class I alloantigen is associated with perturbation of MHC class II-restricted responses by class I-derived peptides.
    Leibnitz RR; Lipsky PE; Thiele DL
    J Immunol; 1995 Aug; 155(4):1784-95. PubMed ID: 7636234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Obliterative airway disease progresses in heterotopic airway allografts without persistent alloimmune stimulus.
    King MB; Pedtke AC; Levrey-Hadden HL; Hertz MI
    Transplantation; 2002 Aug; 74(4):557-62. PubMed ID: 12352919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MHC class I and II antigens as targets of rejection in penetrating keratoplasty in low- and high-risk mouse eyes.
    Osawa H; Streilein JW
    Cornea; 2005 Apr; 24(3):312-8. PubMed ID: 15778605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of anti-allo-class I H-2 tolerance by inactivation of CD8+ helper T cells, and reversal of tolerance through introduction of third-party helper T cells.
    Kitagawa S; Sato S; Hori S; Hamaoka T; Fujiwara H
    J Exp Med; 1990 Jul; 172(1):105-13. PubMed ID: 2141624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monokine induced by interferon-gamma (MIG/CXCL9) is derived from both donor and recipient sources during rejection of class II major histocompatibility complex disparate skin allografts.
    Auerbach MB; Shimoda N; Amano H; Rosenblum JM; Kish DD; Farber JM; Fairchild RL
    Am J Pathol; 2009 Jun; 174(6):2172-81. PubMed ID: 19389928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of airway allograft tolerance by polyinosinic:polycytidylic acid requires type I interferon responsiveness for mouse airway obliteration.
    Miller HL; Shah PD; Orens JB; McDyer JF
    J Heart Lung Transplant; 2013 Sep; 32(9):914-24. PubMed ID: 23953819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Indirectly Activated Treg Allow Dominant Tolerance to Murine Skin-grafts Across an MHC Class I Mismatch After a Single Donor-specific Transfusion.
    Zhang GY; Hu M; Watson D; Wang YM; Knight JF; Alexander SI
    Transplantation; 2020 Jul; 104(7):1385-1395. PubMed ID: 32053573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytotoxicity of Natural Killer Cells Activated Through NKG2D Contributes to the Development of Bronchiolitis Obliterans in a Murine Heterotopic Tracheal Transplant Model.
    Kawakami T; Ito K; Matsuda Y; Noda M; Sakurada A; Hoshikawa Y; Okada Y; Ogasawara K
    Am J Transplant; 2017 Sep; 17(9):2338-2349. PubMed ID: 28251796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.